AVDL News and Press, Avadel Pharmaceuticals plc From 07/01/20

DUBLIN, Ireland, July 01, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, today...

DUBLIN, Ireland, June 08, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, today ...

Investment Thesis As pandemic fears dry up the new patient enrollments, Jazz Pharmaceuticals plc ( JAZZ ) has revised down the 2020 sales guidance, reflecting the impact of rising unemployment on payor reimbursements. The company's excessive reliance on Xyrem is at risk as rival companies ...

DUBLIN, Ireland, June 01, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, today ...

With fears that the second wave of the COVID-19 pandemic is on the horizon, many investors are on the lookout for defensive stocks whose businesses will see little to no impact from a second wave of infections. In cases like this, the best defense is a good offense, and it's usually companies wi...

Image source: The Motley Fool. Avadel Pharmaceuticals plc   (NASDAQ: AVDL) Q1 2020 Earnings Call May 11, 2020 , 8:30 a.m. ET Operator Continue reading

Avadel Pharmaceuticals plc (AVDL) Q1 2020 Earnings Conference Call May 11, 2020 08:30 AM ET Company Participants Thomas McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Jordan Dubow - Chief Medical Officer Conference Call Participants David Amsellem - P...

We previously outlined the bull case for Strongbridge in our article on January 30 , after which the stock declined heavily throughout 1Q 2020. This occurred as major shareholder, Broadfin Capital, was in the process of closing its doors and selling its position, followed by pressure from the...

Avadel Pharmaceuticals (NASDAQ: AVDL ): Q1 GAAP EPS of -$0.02 beats by $0.21 . More news on: Avadel Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news, Read more ...

Reported positive topline data from the pivotal Phase 3 REST-ON study Strengthened balance sheet with $190 million in gross proceeds from a private placement in February 2020 and public equity offering in May 2020   Reported revenue of $12.2 million for the first quarter of ...